Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma [Phase 2]
Phase 2 pediatric trial evaluating pharmacokinetics, safety, and tolerability of a once-daily chewable fevipiprant tablet in children aged 6…
-
FDA approval · 2020-07-15FDA Approved: BUDESONIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for budesonide submitted by Padagis US LLC. The approval updates the labeling for budesonide under t…
-
FDA approval · 2020-07-09FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma's original ANDA for a generic combination of ipratropium bromide and albuterol sulfate.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma [Phase 3]
Phase 3 trial comparing therapeutic equivalence of Fluticasone Propionate/Salmeterol inhalation powder to Advair Diskus in asthma patients h…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients. [Phase 2]
Phase 2 trial assessing the efficacy of a 5-day, 10 mg PBF-680 oral administration for late asthmatic responses in adults with mild to moder…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: C1-inhibitor in Allergic ASThma Patients [Phase 4]
Phase 4 clinical trial update for C1-inhibitor in allergic asthma patients has been terminated.
-
FDA approval · 2020-06-19FDA Approved: TERBUTALINE SULFATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approval of the original application for Terbutaline Sulfate from Upsher-Smith Laboratories, a generic bronchodilator.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma [Phase 4]
Phase 4 clinical trial update on an innovative device aimed at therapeutic adherence in pediatric asthma.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Flexibility and Strength Training in Asthma [NA]
Clinical trial update on flexibility and strength training in asthma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines [Phase 4]
Phase 4 trial investigating the effect of anti-IL-5 therapy on sputum cells and cytokines in asthma.
-
FDA approval · 2020-06-01FDA Approved: KETOTIFEN FUMARATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Unichem Pharmaceuticals (USA), Inc.'s original application for ketotifen fumarate as a generic antihistamine product. This mark…
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma [Phase 3]
Phase 3 long-term safety study of fixed-dose combination therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. [Phase 3]
Phase 3 trial update on QAW039 for severe asthma inadequately controlled with standard therapy, results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma [NA]
Clinical trial update on inhaled steroids at discharge after ED visits for children with uncontrolled asthma; study TERMINATED with results …
-
FDA approval · 2020-05-14FDA Approved: ALBUTEROL — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for ALBUTEROL (albuterol) inhalation product by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of CHF6366 in healthy volunteers and in ast…
-
EMA approval · 2020-04-30First triple combination therapy for asthma with optional electronic sensor
The European Medicines Agency announces the first triple combination therapy for asthma with an optional electronic sensor to monitor adhere…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma [Phase 2, Phase 3]
Clinical trial update for VR506 using a new inhaler in asthma, completed phase 2/3 with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma [Phase 2, Phase 3]
A clinical trial update reports completion of Phase 2 and Phase 3 studies evaluating VR506 via a new inhaler for asthma, with results posted…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels [Phase 2]
Phase 2 clinical trial evaluating L-arginine in severe asthma patients, analyzed by exhaled nitric oxide levels; study completed with result…
-
FDA approval · 2020-04-20FDA Approved: ALBUTEROL SULFATE — Original Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
The FDA approved an original application for a generic albuterol sulfate product by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd., authorizing…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Mast Cell Activation Test in Allergic Disease
Completed clinical trial evaluating a mast cell activation test in allergic diseases; results posted in 2020.
-
FDA approval · 2020-04-08FDA Approved: ALBUTEROL SULFATE — Original Application (American Health Packaging)
FDA approved the original application for albuterol sulfate, a generic product manufactured by American Health Packaging, expanding access t…
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: A Long-term Safety Study of QVM149 in Japanese Patients With Asthma [Phase 3]
Long-term safety study of QVM149 in Japanese patients with asthma has completed Phase 3; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Magnesium Nebulization Utilization in Management of Pediatric Asthma [Phase 2]
Phase 2 clinical trial update exploring magnesium nebulization for managing acute asthma in pediatric patients has completed.